OPUS
Last board
1 director, last change in 2025Director, permanent representative Daniel Pipeleers
in office according to the deed of 03-09-2018
Permanent representatives 1
Daniel Pipeleers
Permanent representative, for Drs Pipeleers & Marichal
in office according to the deed of 03-09-2018
Mandates through the years
6 names, the dashed line is todayDrs Pipeleers & Marichal
Managing director
Managing director
OPUS
Liquidator
Liquidator
Alain Dupont
Director
Director
Sonja Haesen
Director
Director
Frans Gorus
Director
Director
Sabrine Uyttenhove
Director
Director
BoardOther functionEarliermandate already running before its first mentionend not dated
Mandates as a list
- Drs Pipeleers & Marichal
- Managing director, from 01-11-2012 to date
- Managing director, from before 03-09-2018, last mentioned in 2018
- OPUS
- Liquidator, appointed by deed of 15-09-2025, still in office
- Alain Dupont
- Director, until 15-09-2025
- Sonja Haesen
- Director, until 15-09-2025
- Frans Gorus
- Director, from 26-06-2013, last mentioned in 2020
- Sabrine Uyttenhove
- Director, from before 02-07-2020, no longer listed in the 2024 annual accounts
Control
Shareholders
Professor Pipeleers, Vrije Universiteit van Brussel, Diabetes Research Fonds VZW
This company
OPUS
Equity €87,116
Loss €813,879 in 2024
Capital
- Capital
- €61,500
- Source
- 2024 annual accounts
Articles of association
deed of 15-09-2025 (in Dutch)- Custody of recordsThe books and records are kept for at least five years after liquidation. The articles set where.
- “Laarbeeklaan 103, 1090 Brussel, Sabrina Uyttenhove”
Shareholders
Stated in the deed
deed of 11-09-2017 ↗
- Professor Pipeleers 29,154 shares
- Vrije Universiteit van Brussel 28,923 shares
- Diabetes Research Fonds VZW 28,691 shares